Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
drug formulation
Biotech
Moderna's $500M pact with Nanexa to improve injectables delivery
Moderna has tapped Swedish long-acting drug formulation company Nanexa to improve the delivery of up to four injectable therapies.
James Waldron
Dec 11, 2025 7:35am
Pharvaris oral hereditary angioedema med cuts attacks in phase 2
Dec 6, 2023 10:18am
Astellas taps ReForm to improve clinical-phase biologics
Mar 5, 2019 9:39am
After nearly 3 years, FDA lifts hold on Aptose cancer drug
Jun 29, 2018 9:05am
Argenx boosts pipeline with new version of lead drug
Jun 14, 2018 10:50am
Former Pfizer exec invests in $10M for cancer startup
Jun 28, 2016 9:43am
